The persistence of t(14;18)-bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for ‘a lymphoma stem cell’

References

• Godon A, Moreau A, Talmant P, et al. Is t(14;18) (q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 2003; 17: 255–259
   PubMed Web of Science ®Google Scholar
• Hirt C, Dölken G, Janz S, Rabkin C S. Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals. Brit J Haematol 2007; 138: 349–353
   PubMed Web of Science ®Google Scholar
• Bende R J, Smit L A, van Noesel C JM. Molecular pathways in follicular lymphoma. Leukemia 2007; 21: 18–29
   PubMed Web of Science ®Google Scholar
• Cong P, Raffeld M, Teruya-Feldstein J, Sorbara J, Pittaluga S, Jaffe E S. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 2002; 99: 3376–3382
   PubMed Web of Science ®Google Scholar
• Roulland S, Navarro J M, Grenot P, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006; 206: 2425–2431
   Web of Science ®Google Scholar
• Buckstein R, Pennel N, Berinstein N L. What is remission in follicular lymphoma and what is its relevance?. Best Pract Res Clin Hematol 2005; 18: 27–56
   PubMed Web of Science ®Google Scholar
• Foran J M, Gupta R K, Cunningham D, et al. A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response. Br J Haematol 2000; 109: 81–88
   PubMed Web of Science ®Google Scholar
• Mandigers C MPW, Meijerink J PP, Mensink E JBM, et al. Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood 2001; 98: 940–944
   PubMed Web of Science ®Google Scholar
• Schmitt C, Grundt A, Buchholtz C, et al. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: is the end of molecular monitoring near?. Leuk Res 2006; 30: 1563–1568
   PubMed Web of Science ®Google Scholar
• Mandigers C M, Meijerink J P, van't Veer M B, Mensink E J, Raemaekers J M. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma. Ann Hematol 2003; 82: 743–749
   PubMed Web of Science ®Google Scholar
• Gong Y, Caraway N, Gu J, et al. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates. Cancer 2003; 99: 385–393
   PubMed Web of Science ®Google Scholar
• Landgren O, Porwit MacDonald A, Tani E, et al. A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. Hematol J 2004; 5: 69–76
   PubMedGoogle Scholar
• Gribben J G, Freedman A S, Woo S D, et al. All advanced stage Non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275–3280
   PubMed Web of Science ®Google Scholar
• Gribben J G, Neuberg D, Barber M, et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800–3807
   PubMed Web of Science ®Google Scholar
• van Dongen J M, Langerak A W, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
   PubMed Web of Science ®Google Scholar
• Dolken L, Schuler F, Dolken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques 1998; 25: 1058–1064
   PubMed Web of Science ®Google Scholar
• Chiu R W, Murphy M F, Fidler C, Zee B C, Wainscoat J S, Lo Y M. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem 2001; 47: 667–672
   PubMed Web of Science ®Google Scholar
• Cheson B, Horning S, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244–1253
   PubMed Web of Science ®Google Scholar
• Colombat P, Salles G, Brousse N, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for follicular lymphoma patients with a low tumour burden: clinical and molecular evaluation. Blood 2001; 97: 101–106
   PubMed Web of Science ®Google Scholar
• Montoto S, López-Guillermo A, Colomer D, et al. Incidence and clinical significance of Bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma 2003; 44: 71–76
   PubMed Web of Science ®Google Scholar
• Pichert G, Schmitz S F, Hess U, et al. Weekly × 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18) + follicular lymphoma cells. Clin Lymphoma 2001; 4: 293–297
   Google Scholar
• López-Guillermo A, Cabanillas F, McLaughlin P, et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood 1998; 91: 2955–2960
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Lazzari M, Manzoni C, et al. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood 2002; 99: 856–862
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Pulsoni A, Perroti A, et al. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. J Clin Oncol 2004; 22: 2654–2661
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Carlotti E, Oldani E, et al. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood 2005; 105: 3428–3433
   PubMed Web of Science ®Google Scholar
• Summers K E, Davies A J, Matthews J, et al. The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction. Brit J Haematol 2002; 118: 563–566
   PubMed Web of Science ®Google Scholar
• Finke J, Slanina J, Lange W, Dolken G. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 1993; 11: 1668–1673
   PubMed Web of Science ®Google Scholar
• Hirt C, Schüler F, Kiefer T, et al. Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients. Br J Haematol 2008; 141: 631–640
   PubMed Web of Science ®Google Scholar
• Price C G, Meerabux J, Murtagh S, et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9: 1527–1532
   PubMed Web of Science ®Google Scholar
• Hart J, Turner A R, Larratt L, et al. Transmission of a follicular lymphoma by allogeneic bone marrow transplantation – evidence to support the existence of lymphoma progenitor cells. Br J Haematol 2006; 136: 163–172
   Google Scholar
• Dave S S, Wright G, Tan B, Rosenwald A, Gascoyne R D, Chan W C, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159–2169
   PubMed Web of Science ®Google Scholar
• Oeschger S, Bräuninger A, Küppers R, Hansmann M L. Tumour cell dissemination in follicular lymphoma. Blood 2002; 99: 2192–2198
   PubMed Web of Science ®Google Scholar
• Staudt L M. A closer look at follicular lymphoma. N Engl J Med 2007; 356: 741–742
   PubMed Web of Science ®Google Scholar